(VIANEWS) – SPBK1 ØSTFOLD AKE (SOAG.OL), NAVAMEDIC (NAVA.OL), AKER SOLUTIONS (AKSO.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK1 ØSTFOLD AKE (SOAG.OL)
36.1% sales growth and 11.66% return on equity
SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services in Østfold and the southern part of Akershus. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; liquidity loans with government guarantees; operating credit for agriculture; mortgage products; leasing and factoring services; and refinancing services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, truck, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; accounting approved, invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. The company was founded in 1835 and is headquartered in Moss, Norway.
Earnings Per Share
As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr39.15.
PE Ratio
SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 8.02. Meaning, the purchaser of the share is investing kr8.02 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
More news about SPBK1 ØSTFOLD AKE.
2. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 34.49. Meaning, the purchaser of the share is investing kr34.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the current quarter and 17.3% for the next.
Moving Average
NAVAMEDIC’s value is way higher than its 50-day moving average of kr35.37 and way higher than its 200-day moving average of kr36.63.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
Volume
Today’s last reported volume for NAVAMEDIC is 9138 which is 78.93% below its average volume of 43386.
More news about NAVAMEDIC.
3. AKER SOLUTIONS (AKSO.OL)
16.8% sales growth and 17.09% return on equity
Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry worldwide. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of deep-water risers, oil, and gas production, and receiving and processing facilities. In addition, the company provides offshore fish farming, carbon capture, utilization and storage, hydrogen, and offshore wind solutions. Further, the company designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides subsea production, compression, pump, power distribution, and processing systems, and subsea lifecycle services. Furthermore, the company offers maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.41.
PE Ratio
AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 12.33. Meaning, the purchaser of the share is investing kr12.33 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.
Yearly Top and Bottom Value
AKER SOLUTIONS’s stock is valued at kr42.04 at 12:20 EST, way under its 52-week high of kr50.00 and way higher than its 52-week low of kr33.14.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 100% and 16.5%, respectively.
Sales Growth
AKER SOLUTIONS’s sales growth for the next quarter is 16.8%.
More news about AKER SOLUTIONS.
4. SPBK1 HELGELAND (HELG.OL)
13.7% sales growth and 10.8% return on equity
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr14.55.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 8.04. Meaning, the purchaser of the share is investing kr8.04 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.8%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 53.5% and a drop 20.8% for the next.
More news about SPBK1 HELGELAND.
5. DNB BANK (DNB.OL)
12% sales growth and 15.02% return on equity
DNB Bank ASA provides financial services for retail and corporate customers in Norway and internationally. The company offers personal banking products and services, including savings and investment products; loans, such as home mortgages, and car and consumer loans; pet, home and property, travel, and personal insurance products, as well as insurance products for vehicles; retirement savings products; foreign exchange and treasury activities; and Internet and mobile banking services, as well as cards. It also provides business banking products and services comprising savings and investment products consisting of savings accounts, fixed rate deposits, exchange traded products, bonds and commercial papers, asset management, and equity services; financing, such as installment loans, overdraft facility, bank guarantees, leasing, factoring, and trade and export financing services; transaction banking services; research, commodities, bonds and commercial papers, corporate finance, debt capital market, equities, foreign exchange and interest rates, and securities services; and Internet services, including online equity trading, online FX trading, e-confirmation, equities execution, and investor and margin accounts, as well as pension services. In addition, the company provides investment banking services, such as mergers and acquisition, and equity and debt capital market services; foreign exchange, interest rates, equities, commodities, fixed income, research, private equity, and securities services; and corporate banking services. Further, it offers private banking services. The company offers its products and services to various sectors, including energy; financial institutions; healthcare; manufacturing; packaging and forest products; seafood; shipping, offshore, and logistics; and telecom, media, and technology. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, DNB BANK has a trailing twelve months EPS of kr23.23.
PE Ratio
DNB BANK has a trailing twelve months price to earnings ratio of 8.97. Meaning, the purchaser of the share is investing kr8.97 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 74.07B for the twelve trailing months.
Volume
Today’s last reported volume for DNB BANK is 1096140 which is 27.65% below its average volume of 1515220.
Sales Growth
DNB BANK’s sales growth is 24.3% for the current quarter and 12% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 12.5 and the estimated forward annual dividend yield is 5.92%.
More news about DNB BANK.
6. AIRBUS (AIR.PA)
7% sales growth and 26.56% return on equity
Airbus SE engages in the design, manufacture, and delivery of aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft; freighter aircraft; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacture, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; a range of civil and defence space systems for telecommunications, earth observations, navigation, science, and orbital systems; and unmanned aerial systems. This segment also offers missile and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €4.9.
PE Ratio
AIRBUS has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing €24.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.56%.
More news about AIRBUS.
7. MEDISTIM (MEDI.OL)
5.8% sales growth and 34.9% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.26.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 29.47. Meaning, the purchaser of the share is investing kr29.47 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.9%.
Moving Average
MEDISTIM’s value is way under its 50-day moving average of kr224.47 and way under its 200-day moving average of kr246.79.
Volume
Today’s last reported volume for MEDISTIM is 7320 which is 63.13% above its average volume of 4487.
More news about MEDISTIM.
